OBERWEIS ASSET MANAGEMENT INC/ - ANI PHARMACEUTICALS INC ownership

ANI PHARMACEUTICALS INC's ticker is ANIP and the CUSIP is 00182C103. A total of 128 filers reported holding ANI PHARMACEUTICALS INC in Q2 2015. The put-call ratio across all filers is 0.37 and the average weighting 0.2%.

Quarter-by-quarter ownership
OBERWEIS ASSET MANAGEMENT INC/ ownership history of ANI PHARMACEUTICALS INC
ValueSharesWeighting
Q3 2023$1,915,980
-69.4%
33,000
-79.1%
0.20%
-88.8%
Q3 2015$6,252,000
-30.4%
158,235
+9.3%
1.82%
-23.3%
Q2 2015$8,984,000
+98.0%
144,785
+99.6%
2.38%
+86.6%
Q1 2015$4,537,000
+379.1%
72,535
+331.8%
1.27%
+350.2%
Q4 2014$947,00016,8000.28%
Other shareholders
ANI PHARMACEUTICALS INC shareholders Q2 2015
NameSharesValueWeighting ↓
FIRST WILSHIRE SECURITIES MANAGEMENT INC 367,754$10,911,0004.08%
AIGH Capital Management LLC 244,500$7,254,0001.91%
Parkman Healthcare Partners LLC 108,559$3,221,0001.19%
Worth Venture Partners, LLC 60,831$1,927,0001.13%
Global Alpha Capital Management Ltd. 323,731$9,605,0001.04%
Mesirow Financial Investment Management, Inc. 6,892$204,0000.99%
MARATHON CAPITAL MANAGEMENT 74,460$2,209,0000.71%
EMERALD ADVISERS, LLC 455,880$13,526,0000.70%
EMERALD MUTUAL FUND ADVISERS TRUST 356,865$10,588,0000.61%
Jackson Creek Investment Advisors LLC 32,698$1,120,0000.45%
View complete list of ANI PHARMACEUTICALS INC shareholders